Albany, NY -- (SBWIRE) -- 07/25/2013 -- Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players.

To Read The Complete Report with TOC : http://www.marketresearchreports.biz/analysis-details/nilotinib-key-patent-spc-and-data-exclusivity-expiry-44-country-coverage

- This Pipeline Selector report covers Nilotinib
- Nilotinib indications: Treatment of Philadelphia chromosome positive chronic myeloid leukaemia, optionally in combination with erythropoietin, G-CSF, hydroxyurea or Anagrelide
- Nilotinib innovator: Novartis (Tasigna)

To Buy a Copy Of This Report: http://www.marketresearchreports.biz/analysis/168912

Examples of information found in this online report include:
- Includes key patent publications for 44 countries (see list below)
- Contains SPC protection for every EU state plus patent term extensions in other countries
- Data exclusivity calculated on a country by country basis
- Summary of dosage forms, strengths, indications and active ingredient forms of the brand product
- DMF & Paragraph IV filings
- Litigation alerts
- Marketing authorisation holders in selected territories
- Patent risk analysis via graphical display of data from patent filings
- Hyper-linking to crucial patent documents and national registries enabling data verification

Latest Reports:

Ridaforolimus - Key patent, SPC, and data exclusivity expiry (44 country coverage)

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players.This Pipeline Selector report covers Ridaforolimus Ridaforolimus indications: Treatment of cancerRidaforolimus innovator: Ariad; MerckExamples of information found in this online report include:# Includes key patent publications for 44 countries (see list below)# Contains SPC protection for every EU state plus patent term extensions in other countries# Data exclusivity calculated on a country by country basis# Summary of dosage forms, strengths, indications and active ingredient forms of the brand product# D

Apixaban - Comprehensive patent search

magine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information. Pipeline Developer features: Comprehensive patent searching, covering the world's key territories (see 'search c

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/
Blog: http://mresearchreports.blogspot.com/